Oligonucleotide ADC Design and Development – An Emerging Field Building on the Success of ADCs in Cancer

04th April 2022

Create new potential in the ADC oncology space with deep insight and understanding into the innovative field of oligonucleotide bioconjugates,  focusing upon their design, development, analysis and manufacture.

Access the full on-demand webinar from our team of industry experts as they take an in-depth look at their area of specialism.